NovaBay Pharmaceuticals, Inc.
NBY
$0.58
-$0.02-3.33%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 776.00K | 751.00K | 1.82M | 3.13M | 3.47M |
Total Receivables | 704.00K | 547.00K | 734.00K | 759.00K | 916.00K |
Inventory | 498.00K | 700.00K | 667.00K | 2.95M | 3.59M |
Prepaid Expenses | 185.00K | 161.00K | 271.00K | 234.00K | 164.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 116.00K | 94.00K | 96.00K | 81.00K | 76.00K |
Total Current Assets | 2.28M | 2.25M | 3.59M | 7.15M | 8.21M |
|
|||||
Total Current Assets | 2.28M | 2.25M | 3.59M | 7.15M | 8.21M |
Net Property, Plant & Equipment | 1.10M | 1.20M | 1.29M | 1.38M | 1.62M |
Long-term Investments | -- | -- | -- | -- | 348.00K |
Goodwill | -- | -- | -- | -- | 348.00K |
Total Other Intangibles | -- | -- | -- | -- | 2.17M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 495.00K | 476.00K | 477.00K | 497.00K | 501.00K |
Total Assets | 3.88M | 3.93M | 5.36M | 9.03M | 12.85M |
|
|||||
Total Accounts Payable | 396.00K | 1.24M | 1.12M | 1.13M | 947.00K |
Total Accrued Expenses | 396.00K | 524.00K | 521.00K | 570.00K | 827.00K |
Short-term Debt | 51.00K | 696.00K | 1.01M | 1.14M | 1.27M |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 390.00K | 382.00K | 375.00K | 495.00K | 485.00K |
Total Finance Division Other Current Liabilities | 751.00K | 773.00K | 904.00K | 946.00K | 1.04M |
Total Other Current Liabilities | 751.00K | 773.00K | 904.00K | 946.00K | 1.04M |
Total Current Liabilities | 1.98M | 3.61M | 3.92M | 4.28M | 4.57M |
|
|||||
Total Current Liabilities | 1.98M | 3.61M | 3.92M | 4.28M | 4.57M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 51.00K | 696.00K | 1.01M | 1.14M | 1.27M |
Capital Leases | 821.00K | 932.00K | 1.04M | 1.11M | 1.24M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | 232.00K | 334.00K | -- |
Total Liabilities | 2.81M | 4.54M | 5.20M | 5.72M | 5.82M |
|
|||||
Common Stock & APIC | 183.31M | 179.41M | 177.12M | 176.21M | 170.74M |
Retained Earnings | -182.25M | -180.03M | -178.44M | -174.85M | -165.68M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 1.07M | -623.00K | -1.33M | 1.36M | 5.06M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 6.00K | 6.00K | 1.49M | 1.95M | 1.98M |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 6.00K | 6.00K | 1.49M | 1.95M | 1.98M |
|
|||||
Total Common Equity | 1.07M | -623.00K | -1.33M | 1.36M | 5.06M |
Total Preferred Equity | 6.00K | 6.00K | 1.49M | 1.95M | 1.98M |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 1.07M | -617.00K | 160.00K | 3.31M | 7.04M |
|